WHRO Public Media is dedicated to enhancing the lives of the citizens in the communities it serves by responding to their need to be engaged, educated, entertained and enlightened.
The U.S. Food & Drug Administration has cleared a new blood test that can better predict whether pregnant women are at risk of developing pre-eclampsia, one of the world's leading causes of maternal death and disability. The test will help doctors identify which women with high blood pressure need more intensive care and treatment to protect them and their babies from serious complications and possible death. Preeclampsia occurs in about one in 25 pregnancies, predominantly among Black women and after 20 weeks of pregnancy.
/PRNewswire/ The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate.
The FDA approved a blood test (bottom right) that can detect the deadly pregnancy complication preeclampsia with a 96 percent success rate. It s the first development of its kind for the condition.